Cardiovascular disease POC reader AGE

fluorescencefor diabetessepsis

At Diagnoptics we stand with medical professionals who are ready to fight the silent damage caused by Advanced Glycation End products (AGEs) and who believe in acting before symptoms appear. Our mission We’re on a relentless mission to put AGEs at the heart of preventive care Our technology helps health professionals predict complications earlier, personalize treatment and prevent long-term damage before symptoms appear. Why AGEs matter in a clinical context AGEs are dangerous compounds formed through non-enzymatic glycation Advanced Glycation End products crosslink and accumulate in tissue, while oxidative stress and chronic inflammation further drive their formation. AGEs build up in tissues years before clinical symptoms emerge, reflecting long-term metabolic stress. Measuring AGEs uncovers this hidden damage early, adding vital context beyond short-term markers like HbA1c. AGEs impair function of blood vessels, organs, and skin. AGEs are clinically proven drivers of chronic disease. Measuring AGEs improves perioperative risk assessment Innovating metabolic health monitoring The first clinically validated device to non-invasively measure AGEs via Skin Autofluorescence (SAF), introducing a new paradigm beyond glucose and HbA1c, capturing long-term metabolic stress and tissue damage. For healthcare professionals Discover the value of AGE measurement across specialties Cardiology Non-invasive biomarker for vascular risk Diabetology Detect cummulative damage of hyperglycemia Internal medicine Integrative marker for complex patients Peri-operative care Improved risk stratification before surgery Nephrology Assess damage linked to kidney decline